|
|
1)
|
chain |
A |
residue |
54 |
type |
|
sequence |
R
|
description |
BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
|
source |
: PMA
|
|
2)
|
chain |
A |
residue |
55 |
type |
|
sequence |
T
|
description |
BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
|
source |
: PMA
|
|
3)
|
chain |
A |
residue |
105 |
type |
|
sequence |
R
|
description |
BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
|
source |
: PMA
|
|
4)
|
chain |
A |
residue |
134 |
type |
|
sequence |
H
|
description |
BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
|
source |
: PMA
|
|
5)
|
chain |
A |
residue |
137 |
type |
|
sequence |
Q
|
description |
BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
|
source |
: PMA
|
|
6)
|
chain |
A |
residue |
167 |
type |
|
sequence |
R
|
description |
BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
|
source |
: PMA
|
|
7)
|
chain |
A |
residue |
229 |
type |
|
sequence |
R
|
description |
BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
|
source |
: PMA
|
|
8)
|
chain |
A |
residue |
231 |
type |
|
sequence |
Q
|
description |
BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
|
source |
: PMA
|
|
9)
|
chain |
A |
residue |
266 |
type |
|
sequence |
P
|
description |
BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
|
source |
: PMA
|
|
10)
|
chain |
A |
residue |
267 |
type |
|
sequence |
L
|
description |
BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
|
source |
: PMA
|
|
11)
|
chain |
B |
residue |
109 |
type |
|
sequence |
C
|
description |
zn binding site
|
source |
: ZNB
|
|
12)
|
chain |
B |
residue |
114 |
type |
|
sequence |
C
|
description |
zn binding site
|
source |
: ZNB
|
|
13)
|
chain |
B |
residue |
138 |
type |
|
sequence |
C
|
description |
zn binding site
|
source |
: ZNB
|
|
14)
|
chain |
B |
residue |
141 |
type |
|
sequence |
C
|
description |
zn binding site
|
source |
: ZNB
|
|
15)
|
chain |
B |
residue |
8 |
type |
|
sequence |
G
|
description |
ALLOSTERIC BINDING SITE
|
source |
: ATB
|
|
16)
|
chain |
B |
residue |
9 |
type |
|
sequence |
V
|
description |
ALLOSTERIC BINDING SITE
|
source |
: ATB
|
|
17)
|
chain |
B |
residue |
10 |
type |
|
sequence |
E
|
description |
ALLOSTERIC BINDING SITE
|
source |
: ATB
|
|
18)
|
chain |
B |
residue |
11 |
type |
|
sequence |
A
|
description |
ALLOSTERIC BINDING SITE
|
source |
: ATB
|
|
19)
|
chain |
B |
residue |
12 |
type |
|
sequence |
I
|
description |
ALLOSTERIC BINDING SITE
|
source |
: ATB
|
|
20)
|
chain |
B |
residue |
19 |
type |
|
sequence |
D
|
description |
ALLOSTERIC BINDING SITE
|
source |
: ATB
|
|
21)
|
chain |
B |
residue |
20 |
type |
|
sequence |
H
|
description |
ALLOSTERIC BINDING SITE
|
source |
: ATB
|
|
22)
|
chain |
B |
residue |
56 |
type |
|
sequence |
K
|
description |
ALLOSTERIC BINDING SITE
|
source |
: ATB
|
|
23)
|
chain |
B |
residue |
60 |
type |
|
sequence |
K
|
description |
ALLOSTERIC BINDING SITE
|
source |
: ATB
|
|
24)
|
chain |
B |
residue |
84 |
type |
|
sequence |
N
|
description |
ALLOSTERIC BINDING SITE
|
source |
: ATB
|
|
25)
|
chain |
B |
residue |
89 |
type |
|
sequence |
Y
|
description |
ALLOSTERIC BINDING SITE
|
source |
: ATB
|
|
26)
|
chain |
B |
residue |
94 |
type |
|
sequence |
K
|
description |
ALLOSTERIC BINDING SITE
|
source |
: ATB
|
|
27)
|
chain |
C |
residue |
54 |
type |
|
sequence |
R
|
description |
BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
|
source |
: PMC
|
|
28)
|
chain |
C |
residue |
55 |
type |
|
sequence |
T
|
description |
BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
|
source |
: PMC
|
|
29)
|
chain |
C |
residue |
105 |
type |
|
sequence |
R
|
description |
BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
|
source |
: PMC
|
|
30)
|
chain |
C |
residue |
134 |
type |
|
sequence |
H
|
description |
BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
|
source |
: PMC
|
|
31)
|
chain |
C |
residue |
137 |
type |
|
sequence |
Q
|
description |
BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
|
source |
: PMC
|
|
32)
|
chain |
C |
residue |
167 |
type |
|
sequence |
R
|
description |
BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
|
source |
: PMC
|
|
33)
|
chain |
C |
residue |
229 |
type |
|
sequence |
R
|
description |
BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
|
source |
: PMC
|
|
34)
|
chain |
C |
residue |
231 |
type |
|
sequence |
Q
|
description |
BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
|
source |
: PMC
|
|
35)
|
chain |
C |
residue |
266 |
type |
|
sequence |
P
|
description |
BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
|
source |
: PMC
|
|
36)
|
chain |
C |
residue |
267 |
type |
|
sequence |
L
|
description |
BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
|
source |
: PMC
|
|
37)
|
chain |
D |
residue |
109 |
type |
|
sequence |
C
|
description |
zn binding site
|
source |
: ZND
|
|
38)
|
chain |
D |
residue |
114 |
type |
|
sequence |
C
|
description |
zn binding site
|
source |
: ZND
|
|
39)
|
chain |
D |
residue |
138 |
type |
|
sequence |
C
|
description |
zn binding site
|
source |
: ZND
|
|
40)
|
chain |
D |
residue |
141 |
type |
|
sequence |
C
|
description |
zn binding site
|
source |
: ZND
|
|
41)
|
chain |
A |
residue |
55 |
type |
catalytic |
sequence |
T
|
description |
405
|
source |
MCSA : MCSA1
|
|
42)
|
chain |
A |
residue |
56 |
type |
catalytic |
sequence |
R
|
description |
405
|
source |
MCSA : MCSA1
|
|
43)
|
chain |
A |
residue |
85 |
type |
catalytic |
sequence |
G
|
description |
405
|
source |
MCSA : MCSA1
|
|
44)
|
chain |
A |
residue |
106 |
type |
catalytic |
sequence |
H
|
description |
405
|
source |
MCSA : MCSA1
|
|
45)
|
chain |
A |
residue |
135 |
type |
catalytic |
sequence |
P
|
description |
405
|
source |
MCSA : MCSA1
|
|
46)
|
chain |
C |
residue |
55 |
type |
catalytic |
sequence |
T
|
description |
405
|
source |
MCSA : MCSA2
|
|
47)
|
chain |
C |
residue |
56 |
type |
catalytic |
sequence |
R
|
description |
405
|
source |
MCSA : MCSA2
|
|
48)
|
chain |
C |
residue |
85 |
type |
catalytic |
sequence |
G
|
description |
405
|
source |
MCSA : MCSA2
|
|
49)
|
chain |
C |
residue |
106 |
type |
catalytic |
sequence |
H
|
description |
405
|
source |
MCSA : MCSA2
|
|
50)
|
chain |
C |
residue |
135 |
type |
catalytic |
sequence |
P
|
description |
405
|
source |
MCSA : MCSA2
|
|
51)
|
chain |
A |
residue |
48-55 |
type |
prosite |
sequence |
FFEASTRT
|
description |
CARBAMOYLTRANSFERASE Aspartate and ornithine carbamoyltransferases signature. FfEaSTRT
|
source |
prosite : PS00097
|
|
52)
|
chain |
B |
residue |
110 |
type |
BINDING |
sequence |
P
|
description |
|
source |
Swiss-Prot : SWS_FT_FI1
|
|
53)
|
chain |
C |
residue |
106 |
type |
BINDING |
sequence |
H
|
description |
|
source |
Swiss-Prot : SWS_FT_FI1
|
|
54)
|
chain |
C |
residue |
135 |
type |
BINDING |
sequence |
P
|
description |
|
source |
Swiss-Prot : SWS_FT_FI1
|
|
55)
|
chain |
C |
residue |
138 |
type |
BINDING |
sequence |
T
|
description |
|
source |
Swiss-Prot : SWS_FT_FI1
|
|
56)
|
chain |
C |
residue |
268 |
type |
BINDING |
sequence |
P
|
description |
|
source |
Swiss-Prot : SWS_FT_FI1
|
|
57)
|
chain |
C |
residue |
269 |
type |
BINDING |
sequence |
R
|
description |
|
source |
Swiss-Prot : SWS_FT_FI1
|
|
58)
|
chain |
B |
residue |
115 |
type |
BINDING |
sequence |
I
|
description |
|
source |
Swiss-Prot : SWS_FT_FI1
|
|
59)
|
chain |
B |
residue |
139 |
type |
BINDING |
sequence |
K
|
description |
|
source |
Swiss-Prot : SWS_FT_FI1
|
|
60)
|
chain |
B |
residue |
142 |
type |
BINDING |
sequence |
E
|
description |
|
source |
Swiss-Prot : SWS_FT_FI1
|
|
61)
|
chain |
D |
residue |
110 |
type |
BINDING |
sequence |
P
|
description |
|
source |
Swiss-Prot : SWS_FT_FI1
|
|
62)
|
chain |
D |
residue |
115 |
type |
BINDING |
sequence |
I
|
description |
|
source |
Swiss-Prot : SWS_FT_FI1
|
|
63)
|
chain |
D |
residue |
139 |
type |
BINDING |
sequence |
K
|
description |
|
source |
Swiss-Prot : SWS_FT_FI1
|
|
64)
|
chain |
D |
residue |
142 |
type |
BINDING |
sequence |
E
|
description |
|
source |
Swiss-Prot : SWS_FT_FI1
|
|
65)
|
chain |
C |
residue |
56 |
type |
BINDING |
sequence |
R
|
description |
|
source |
Swiss-Prot : SWS_FT_FI1
|
|
66)
|
chain |
A |
residue |
85 |
type |
BINDING |
sequence |
G
|
description |
BINDING => ECO:0000255|HAMAP-Rule:MF_00001, ECO:0000305|PubMed:3380787
|
source |
Swiss-Prot : SWS_FT_FI2
|
|
67)
|
chain |
A |
residue |
168 |
type |
BINDING |
sequence |
T
|
description |
BINDING => ECO:0000255|HAMAP-Rule:MF_00001, ECO:0000305|PubMed:3380787
|
source |
Swiss-Prot : SWS_FT_FI2
|
|
68)
|
chain |
A |
residue |
230 |
type |
BINDING |
sequence |
V
|
description |
BINDING => ECO:0000255|HAMAP-Rule:MF_00001, ECO:0000305|PubMed:3380787
|
source |
Swiss-Prot : SWS_FT_FI2
|
|
69)
|
chain |
C |
residue |
85 |
type |
BINDING |
sequence |
G
|
description |
BINDING => ECO:0000255|HAMAP-Rule:MF_00001, ECO:0000305|PubMed:3380787
|
source |
Swiss-Prot : SWS_FT_FI2
|
|
70)
|
chain |
C |
residue |
168 |
type |
BINDING |
sequence |
T
|
description |
BINDING => ECO:0000255|HAMAP-Rule:MF_00001, ECO:0000305|PubMed:3380787
|
source |
Swiss-Prot : SWS_FT_FI2
|
|
71)
|
chain |
C |
residue |
230 |
type |
BINDING |
sequence |
V
|
description |
BINDING => ECO:0000255|HAMAP-Rule:MF_00001, ECO:0000305|PubMed:3380787
|
source |
Swiss-Prot : SWS_FT_FI2
|
|